CORRECTION OF IRON-DEFICIENCY ANEMIA IN PREGNANT WOMEN
- Authors: Tyutyunnik V.L.1, Kan N.E.1, Mikhailova O.I.1
-
Affiliations:
- National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia
- Issue: No 8 (2018)
- Pages: 106-110
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248336
- ID: 248336
Cite item
Open Access
Access granted
Abstract
Objective. To investigate the efficiency of Tardyferon treatment for manifest iron deficiency in pregnant women. Subjects and methods. A total of 108 women with singleton pregnancy and mild iron-deficiency anemia (IDA) have been followed up during 2017-2018. Group 1 (a study group) consisted of 55 pregnant women treated for IDA with an iron sulfate-containing drug (Tardyferon); Group 2 (a comparison group) comprised 53 pregnant women treated for IDA with iron (III)-hydroxide polymaltosate complex containing 100 mg of iron. Results. The key hemogram indicators in Group 1 patients treated with Tardyferon were higher than those in Group 2. Side effects were noted in 21 (39.6%) patients treated with iron (III)-hydroxide polymaltose complex and in 5 (9.1%) pregnant women using Tardyferon, which suggests its good tolerance and, accordingly, high treatment adherence. Conclusion. The anemic pregnant women treated with iron preparations show a significant normalization of ferrokinetic parameters, which leads to improved tissue oxygenation and favorable changes in a pregnant women with anemia and, as a result, to a positive clinical effect.
Keywords
Full Text
About the authors
Victor L. Tyutyunnik
National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia
Email: tioutiounnik@mail.ru
MD, head of the 1st Obstetric Physiological Department Moscow 117997, Ac. Oparina str. 4, Russia
Natalia E. Kan
National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia
Email: kan-med@mail.ru
MD, head of the obstetric department Moscow 117997, Ac. Oparina str. 4, Russia
Olga I. Mikhailova
National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia
Email: o_mikhailova@oparina4.ru
Ph.D., scientific employee of obstetric department Moscow 117997, Ac. Oparina str. 4, Russia
References
- Коноводова Е.Н., Тютюнник В.Л., Якунина Н.А., Подымова А.А. Эффективность лечения латентного дефицита железа у беременных с хроническим пиелонефритом. Акушерство и гинекология. 2012; 8-2: 90-5
- Серов В.Н., Бурлев В.А., Коноводова Е.Н., Кан Н.Е., Тютюнник В.Л. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц (клинический протокол). Акушерство и гинекология. 2014; 3 (Приложение): 11-7
- World Health Organization. Global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015.
- Di Renzo G.C., Spano F., Giardina I., Brillo E., Clerici G., Roura L.C. Iron deficiency anemia in pregnancy. Womens Health (Lond.). 2015; 11(6): 891-900.
- Shao J., Lou J., Rao R., Georgieff M.K., Kaciroti N., Felt B.T. et al. Maternal serum ferritin concentration is positively associated with newborn iron stores in women with low ferritin status in late pregnancy. J. Nutr. 2012; 142(11): 2004-9.
- Доброхотова Ю.Э., Бахарева И.В. Железодефицитная анемия: профилактика и лечение при беременности. Лечебное дело. 2016; 3: 4-14.
- Lebso M., Anato A., Loha E. Prevalence of anemia and associated factors among pregnant women in Southern Ethiopia: A community based cross-sectional study. PLoS One. 2017; 12(12): e0188783.
- Taylor C.L., Brannon P.M. Introduction to workshop on iron screening and supplementation in iron-replete pregnant women and young children. Am. J. Clin. Nutr. 2017; 106(Suppl. 6): 1547-54.
- Haider B.A., Bhutta Z.A. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst. Rev. 2015; (11): CD004905.
- Коноводова Е.Н., Бурлев В.А. Железодефицитные состояния у беременных и родильниц. Акушерство и гинекология. 2012: 1: 137-42
- Хух Р., Брейман К. Анемия во время беременности и в послеродовом периоде. М.: Триада-Х; 2007. 73с
- Федеральные клинические рекомендации. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц. М.: Российское общество акушеров-гинекологов, ФГБУ «Научный центр акушерства, гинекологии и перинатологии им. В.И. Кулакова» Минздрава России; 2013
- Badfar G., Shohani M., Soleymani A., Azami M. Maternal anemia during pregnancy and small for gestational age: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 2018; Jan. 10: 1-7.
- Железодефицитная анемия. Клинические рекомендации (протоколы лечения). Национальный стандарт Российской Федерации (проект). М.; 2015.
- Friedrisch J.R., Friedrisch B.K. Prophylactic iron supplementation in pregnancy: a controversial issue. Biochem. Insights. 2017; Oct. 27: 10.
- Choudhury N., Aimone A., Hyder S.M., Zlotkin S.H. Relative efficacy of micronutrient powders versus iron-folic acid tablets in controlling anemia in women in the second trimester of pregnancy. Food Nutr. Bull. 2012; 33(2): 142-9.
- Breymann C., Milman N., Mezzacasa A., Bernard R., Dudenhausen J.; FER-ASAP investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J. Perinat. Med. 2017; 45(4): 443-53.
- Батищева Г.А., Мубаракшина О.А., Сомова М.Н., Мубаракшин Э.А., Барбашина К.В. Фармакологическая коррекция железодефицитной анемии при беременности. Акушерство и гинекология. 2015; 12: 122-126.
Supplementary files
